Clinical impact of FLT3 mutation load in acute promyelocytic leukemia with t(15;17)/PML-RARA
Background Combined treatment with all-trans-retinoic acid and chemotherapy is extremely efficient in patients with acute promyelocytic leukemia with t(15;17)/PML-RARA, but up to 15% of patients relapse.Design and Methods To further clarify the prognostic impact of parameters such as FLT3 mutations,...
| Main Authors: | , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Ferrata Storti Foundation
2011-12-01
|
| Series: | Haematologica |
| Online Access: | https://haematologica.org/article/view/6152 |